Atlas Trials

Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO

Clinical trial NCT01624571 · COMPLETED

Trial details

NCT number
NCT01624571
Sponsor
LG Life Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colon Resection_large Interstinal Surgery
Start date
2012-03-01
Primary completion
2012-10-01
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.